Survival and complications after neoadjuvant chemotherapy or chemoradiotherapy for esophageal cancer: a meta-analysis

被引：38
|
作者：
Han, Jinmin [2 ,3 ,4 ]
Wang, Zhongtang [3 ,4 ]
Liu, Chengxin [1 ,3 ,4 ,5 ]
机构：
[1] Shandong Univ, Cheeloo Coll Med, Jinan 250012, Peoples R China
[2] Shandong First Med Univ, Jinan 250117, Peoples R China
[3] Shandong Acad Med Sci, Jinan 250117, Peoples R China
[4] Shandong First Med Univ, Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan 250117, Peoples R China
[5] Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan 250117, Peoples R China
来源：
FUTURE ONCOLOGY | 2021年 / 17卷 / 17期
基金：
中国国家自然科学基金;
关键词：
complications; esophageal cancer; meta-analysis; neoadjuvant treatment; survival; PHASE-III TRIAL; PREOPERATIVE CHEMORADIOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; RESECTABLE ESOPHAGEAL; CHEMORADIATION; THERAPY; ADENOCARCINOMA; CARCINOMA; SURGERY; RADIOCHEMOTHERAPY;
D O I：
10.2217/fon-2021-0021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Objectives: To identify the effective approach between neoadjuvant chemotherapy (NCT) and chemoradiotherapy (NCRT) by comparing patient survival and complications. Methods: A systematic literature search of articles published between January 1980 and October 2020 was conducted. Data were extracted and analyzed with STATA 12.0. Results: Five randomized trials and 15 retrospective studies, including 4529 patients (NCT: 2035; NCRT: 2494), were enrolled. Compared with NCT, NCRT provided a higher 3-year survival benefit, higher R0 resection and pathological complete response rates and lower local recurrence and distant metastasis rates, but no increase in 5-year survival. Perioperative mortality and cardiovascular complications were more common in patients with adenocarcinoma. Conclusions: Further studies should concentrate on identifying the optimal neoadjuvant approach and suitable beneficiaries.
引用
收藏
页码：2257 / 2274
页数：18
相关论文
共 50 条
  • [21] A Systematic Review and Meta-analysis of Survival and Surgical Outcomes Following Neoadjuvant Chemoradiotherapy for Pancreatic Cancer
    Laurence, Jerome Martin
    Peter Duy Tran
    Morarji, Kavita
    Eslick, Guy D.
    Vincent Wai To Lam
    Sandroussi, Charbel
    JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (11) : 2059 - 2069
  • [22] Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis
    Liu, Yunsong
    Bao, Yongxing
    Yang, Xu
    Sun, Shuang
    Yuan, Meng
    Ma, Zeliang
    Zhang, Wanting
    Zhai, Yirui
    Wang, Yang
    Men, Yu
    Qin, Jianjun
    Xue, Liyan
    Wang, Jun
    Hui, Zhouguang
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [23] Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis
    Sjoquist, Katrin M.
    Burmeister, Bryan H.
    Smithers, B. Mark
    Zalcberg, John R.
    Simes, R. John
    Barbour, Andrew
    Gebski, Val
    LANCET ONCOLOGY, 2011, 12 (07) : 681 - 692
  • [24] Impact of pathological complete response following neoadjuvant chemoradiotherapy in esophageal cancer
    Soror, Tamer
    Kho, Gerlinda
    Zhao, Kuai-Le
    Ismail, Mahmoud
    Badakhshi, Harlin
    JOURNAL OF THORACIC DISEASE, 2018, 10 (07) : 4069 - 4076
  • [25] Neoadjuvant chemoradiotherapy, chemotherapy, and radiotherapy do not significantly increase the incidence of anastomotic leakage after esophageal cancer surgery: a meta-analysis
    Jin, Zixian
    Zhang, Jian
    Chen, Dong
    Wu, Sikai
    Xue, Penglai
    Zhu, Kanghao
    Xu, Congcong
    Zhu, Chengchu
    Zhang, Bo
    DISEASES OF THE ESOPHAGUS, 2022, 35 (09)
  • [26] Staging accuracy of endoscopic ultrasound for esophageal cancer after neoadjuvant chemotherapy: a meta-analysis and systematic review
    Sun, F.
    Chen, T.
    Han, J.
    Ye, P.
    Hu, J.
    DISEASES OF THE ESOPHAGUS, 2015, 28 (08): : 757 - 771
  • [27] Neoadjuvant chemoradiotherapy for resectable gastric cancer: A meta-analysis
    Chen, Jiuzhou
    Guo, Yaru
    Fang, Miao
    Yuan, Yan
    Zhu, Youqi
    Xin, Yong
    Zhang, Longzhen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy
    Cabrit, Nicolas
    Cheugoua-Zanetsie, Maurice
    Tierney, Jayne
    Thirion, Pierre
    Nankivell, Matthew
    Winter, Kathryn
    Yang, Hong
    Wijnhoven, Bas
    Vernerey, Dewi
    Smithers, B. Mark
    Piessen, Guillaume
    Nilsson, Magnus
    Boonstra, Jurjen
    Ychou, Marc
    Law, Simon
    Cunningham, David
    de Vathaire, Florent
    Stahl, Michael
    Urba, Susan
    Valmasoni, Michele
    Williaume, Daniele
    Thomas, Janine
    Lordick, Florian
    Tepper, Joel
    Gebski, Val
    Burmeister, Bryan
    Paoletti, Xavier
    van Sandick, Johanna
    Fu, Jianhua
    Pignon, Jean-Pierre
    Ducreux, Michel
    Faron, Matthieu
    Michiels, Stefan
    EUROPEAN JOURNAL OF CANCER, 2025, 218
  • [29] Increasing the interval between neoadjuvant chemoradiotherapy and surgery in esophageal cancer: a meta-analysis of published studies
    Lin, G.
    Han, S. -Y.
    Xu, Y. -P.
    Mao, W. -M.
    DISEASES OF THE ESOPHAGUS, 2017, 30 (07): : 1107 - 1114
  • [30] Systematic review and meta-analysis of endoscopic ultrasonography in staging diagnosis of esophageal cancer after neoadjuvant radiotherapy and chemotherapy
    Li, Xiaodong
    Wang, Yixiao
    Kong, Min
    Lin, Jiang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (04) : 1525 - 1540
12345